Correlation Between Pfizer and Dechra Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pfizer and Dechra Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Dechra Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Dechra Pharmaceuticals PLC, you can compare the effects of market volatilities on Pfizer and Dechra Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Dechra Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Dechra Pharmaceuticals.
Diversification Opportunities for Pfizer and Dechra Pharmaceuticals
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and Dechra is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Dechra Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dechra Pharmaceuticals and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Dechra Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dechra Pharmaceuticals has no effect on the direction of Pfizer i.e., Pfizer and Dechra Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pfizer and Dechra Pharmaceuticals
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Dechra Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.87 times less risky than Dechra Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Dechra Pharmaceuticals PLC is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 7,124 in Dechra Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of 2,254 from holding Dechra Pharmaceuticals PLC or generate 31.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 30.85% |
| Values | Daily Returns |
Pfizer Inc vs. Dechra Pharmaceuticals PLC
Performance |
| Timeline |
| Pfizer Inc |
| Dechra Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pfizer and Dechra Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Dechra Pharmaceuticals
The main advantage of trading using opposite Pfizer and Dechra Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Dechra Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dechra Pharmaceuticals will offset losses from the drop in Dechra Pharmaceuticals' long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
| Dechra Pharmaceuticals vs. Pfizer Inc | Dechra Pharmaceuticals vs. Sanofi ADR | Dechra Pharmaceuticals vs. Bristol Myers Squibb | Dechra Pharmaceuticals vs. AstraZeneca PLC ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |